HealthTech: Early stage Alzheimer’s | Detecting diseases more quickly
September 8, 2021
PITTSBURGH, PA—Researchers from the University of Pittsburgh have just completed a study involving living patients that may bring hope to those with Alzheimer’s. The study findings suggest that targeting neuroinflammation might be beneficial for people with early-stage Alzheimer’s disease and that it might help reverse or at least slow down the accumulation of pathologic tau protein in the brain and stave off dementia.
WEST LAYFAYETTE, IN—Life sciences company Amplified Sciences, which is developing diagnostics designed to detect debilitating diseases more quickly, has closed on an $1.8 million seed round. Investors include Chicago-based OCA Ventures, Purdue Ventures, Indiana University Ventures, the IU Angel Network, New York-based Golden Seeds, Houston Angel Network, Chemical Angel Network in California, and Gravity Ventures in Indianapolis.